Changing the Game in Drug Development Brochure 改变药物开发的局面 At Certara, we are innovators, dedicated to helping our clients develop new therapies and target…Certara2018 年 3 月 19 日
Using a Pharmacology to Payer Framework to Support Product Development Blog Using a Pharmacology to Payer Framework to Support Product Development Modeling and simulation (M&S) of complex systems has primarily advanced vertically in differing scientific domains…Certara2018 年 3 月 16 日
An Analysis on Distribution and Inter-relationships of Biomarkers Under Rivaroxaban in Japanese Patients with Non-valvular Atrial Fibrillation (CVI ARO 1) Publication An Analysis on Distribution and Inter-relationships of Biomarkers Under Rivaroxaban in Japanese Patients with Non-valvular Atrial Fibrillation (CVI ARO 1) Certara2018 年 3 月 15 日
The Many Challenges of Narrative Writing Blog The Many Challenges of Narrative Writing Narratives are an essential part of any programs’ story, but often become cumbersome due to…Certara2018 年 3 月 13 日
Using Virtual Twin Technology to Predict Drug Exposure in Individual Patients On-Demand Webinar Using Virtual Twin Technology to Predict Drug Exposure in Individual Patients In this webinar, Dr. Tom Polasek, a clinical pharmacologist at Certara Strategic Consulting, explained how…Certara2018 年 3 月 8 日
Skin in the Game: Mechanistic Modeling of Dermal Drug Absorption Blog Skin in the Game: Mechanistic Modeling of Dermal Drug Absorption The ability to estimate systemic exposure from dermal absorption is essential in developing new dermatological…Certara2018 年 3 月 2 日
Cost-utility Analysis of Antiviral Use Under Pandemic Influenza Using a Novel Approach—Linking Pharmacology, Epidemiology and Heath Economics Publication Cost-utility Analysis of Antiviral Use Under Pandemic Influenza Using a Novel Approach—Linking Pharmacology, Epidemiology and Heath Economics Certara2018 年 3 月 1 日